Table 2. Distribution of comorbidities in patients undergoing multivessel percutaneous coronary interventions.
| Comorbidity | White, % | Black, % | Hispanic, % | Asian, % | Native American, % | Other, % | P | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | |||||||
| Alcohol abuse | 3.5 | 1.0 | 4.2 | 1.0 | 3.6 | 0.3 | 1.0 | 0.2 | 4.8 | 0.2 | 2.8 | 1.1 | <0.001 | |||||
| Congestive heart failure | 3.4 | 4.3 | 6.5 | 7.7 | 4.6 | 5.8 | 3.3 | 4.8 | 3.5 | 4.9 | 2.5 | 4.6 | <0.001 | |||||
| Chronic pulmonary disease | 20.2 | 26.0 | 15.7 | 19.5 | 11.6 | 14.9 | 9.7 | 11.6 | 20.3 | 18.6 | 14.3 | 19.1 | <0.001 | |||||
| Coagulopathy | 4.1 | 3.8 | 4.6 | 4.3 | 4.4 | 4.5 | 4.2 | 6.6 | 3.6 | 4.4 | 4.1 | 4.2 | <0.001 | |||||
| Diabetes, uncomplicated | 27.9 | 29.0 | 30.6 | 36.3 | 35.9 | 40.2 | 37.9 | 40.0 | 36.3 | 45.3 | 33.1 | 37.7 | <0.001 | |||||
| Diabetes with complications | 8.7 | 9.4 | 16.7 | 18.6 | 19.0 | 23.0 | 11.6 | 15.6 | 17.5 | 18.5 | 8.8 | 13.1 | <0.001 | |||||
| Drug abuse | 1.4 | 0.9 | 5.4 | 2.3 | 1.9 | 0.8 | 0.7 | 0.7 | 2.2 | 0.2 | 1.7 | 1.0 | <0.001 | |||||
| Smoking | 46.9 | 39.2 | 42.7 | 32.8 | 35.8 | 20.1 | 34.5 | 13.9 | 41.7 | 32.2 | 39.7 | 28.9 | <0.001 | |||||
| Hypertension | 74.7 | 76.9 | 82.5 | 83.6 | 78.9 | 80.4 | 74.5 | 80.6 | 79.6 | 81.2 | 76.4 | 78.7 | <0.001 | |||||
| Liver disease | 1.5 | 1.2 | 2.6 | 1.5 | 2.3 | 1.7 | 1.7 | 1.9 | 1.3 | 1.2 | 1.1 | 1.1 | <0.001 | |||||
| Obesity | 12.7 | 14.9 | 10.7 | 18.3 | 11.5 | 16.5 | 5.3 | 7.1 | 12.8 | 15.7 | 10.4 | 15.0 | <0.001 | |||||
| Peripheral vascular disorders | 28.7 | 34.4 | 34.1 | 37.7 | 30.9 | 36.9 | 18.0 | 26.6 | 37.7 | 42.4 | 22.5 | 31.0 | <0.001 | |||||
| Pulmonary circulation disorders | 0.7 | 1.3 | 1.3 | 2.1 | 0.8 | 1.3 | 0.5 | 1.5 | 0.3 | 1.1 | 0.5 | 0.9 | <0.001 | |||||
| Renal failure | 17.5 | 18.4 | 38.5 | 40.6 | 28.4 | 32.3 | 23.1 | 32.1 | 25.3 | 28.7 | 18.6 | 24.8 | <0.001 | |||||
| Valvular heart disease | 1.4 | 2.3 | 1.6 | 2.3 | 1.4 | 1.9 | 0.9 | 1.1 | 1.4 | 1.1 | 0.8 | 1.8 | <0.001 | |||||
| Dyslipidemia | 66.1 | 61.5 | 54.9 | 52.2 | 63.1 | 58.6 | 70.6 | 63.1 | 61.5 | 56.5 | 65.4 | 60.0 | <0.001 | |||||
| Atherosclerosis | 30.7 | 38.3 | 34.3 | 40.6 | 29.5 | 37.6 | 17.9 | 27.0 | 37.6 | 43.4 | 23.6 | 33.2 | <0.001 | |||||
| Cardiomyopathy | 4.5 | 3.9 | 7.6 | 5.7 | 5.0 | 5.2 | 5.7 | 4.6 | 3.9 | 5.1 | 3.5 | 4.5 | <0.001 | |||||
| Cerebrovascular Diseases | 2.0 | 3.0 | 2.4 | 2.9 | 2.2 | 2.5 | 1.9 | 4.8 | 1.0 | 2.5 | 2.4 | 2.5 | <0.001 | |||||
| Thromboembolism | 5.9 | 8.2 | 10.4 | 12.3 | 5.2 | 8.0 | 3.1 | 7.1 | 4.6 | 6.7 | 4.2 | 7.6 | <0.001 | |||||
| Previous history of MI | 15.3 | 11.6 | 12.8 | 10.8 | 13.1 | 10.3 | 13.6 | 11.4 | 12.4 | 10.5 | 13.2 | 9.6 | <0.001 | |||||
| Family history of CAD | 8.8 | 7.0 | 4.5 | 3.7 | 6.1 | 4.4 | 7.6 | 4.1 | 6.8 | 6.7 | 8.6 | 6.9 | <0.001 | |||||
| Previous PCI | 18.7 | 14.7 | 14.0 | 12.4 | 15.1 | 13.2 | 17.5 | 13.9 | 16.0 | 11.8 | 18.5 | 14.6 | <0.001 | |||||
| Previous CABG | 13.4 | 8.9 | 8.2 | 7.2 | 10.8 | 9.8 | 10.5 | 10.5 | 14.0 | 10.1 | 10.2 | 8.6 | <0.001 | |||||
MI, myocardial infarction; CAD, coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.